The company reported $616.5 million in fourth quarter sales, an increase of 124.6%, and full year sales of $1.6 billion, a 53.3% increase over the prior year, according to a news release. Globus Medical has also maintained its 2024 guidance range of $2.45 billion to $2.5 billion.
This year will be the first full year Globus Medical will be operating under its merger with NuVasive. In 2024, the company is anticipating the launch of a flagship knee robot.
